transitioning from tirzepatide to retatrutide vs for weight loss and body recomp Retatrutide vs Tirzepatide (2026) |

90 (Suppl 4), 1012 (2012)

The Fueled Framework does not provide medical advice

The State Health Plan Board of Trustees concluded that coverage of these drugs for weight loss purposes was no longer financially feasible and would have required a premium increase of $48.50 per member per month

Pocai A, Carrington PE, Adams JR, Wright M, Eiermann G, Zhu L, Du X, Petrov A, Lassman ME, Jiang G, Liu F, Miller C, Tota LM, Zhou G, Zhang X, Sountis MM, Santoprete A, Capito E, Chicchi GG, Thornberry N, Bianchi E, Pessi A, Marsh DJ, Sinha RR

Check your eligibility Checking eligibility involves verifying that your current plan doesn't already cover the medication for weight loss and that you meet the clinical criteria

Da Silva Ferreira, C